Abstract
In this case report, we present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term. The postpartum and neonatal courses were uncomplicated. Anti-SARS-CoV-2-IgG antibodies were detected in the neonate. A vaginal delivery in this case was safe with clinical diagnosis of COVID-19.
Highlights
To date, there are only limited data about the effect of novel coronavirus (SARS-CoV-2) infection on pregnancy, delivery and placental transfer of antibodies
We present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term
We report a pregnant woman in her 33 weeks gestation diagnosed with COVID-19 by PCR and serology, who delivered a healthy, but Anti-SARS-CoV2-IgG-positive infant
Summary
There are only limited data about the effect of novel coronavirus (SARS-CoV-2) infection on pregnancy, delivery and placental transfer of antibodies. We present a pregnant woman diagnosed with COVID-19 at 33 weeks gestation and having a vaginal birth at term. Anti-SARS-CoV-2-IgG antibodies were detected in the neonate. A vaginal delivery in this case was safe with clinical diagnosis of COVID-19.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
